<SEC-DOCUMENT>0001021561-13-000066.txt : 20130709
<SEC-HEADER>0001021561-13-000066.hdr.sgml : 20130709
<ACCEPTANCE-DATETIME>20130709170228
ACCESSION NUMBER:		0001021561-13-000066
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130630
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130709
DATE AS OF CHANGE:		20130709

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES INC
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		13960198

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: D. MATTHEW DORNY
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-6100

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: D. MATTHEW DORNY
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pre2q-8k.htm
<DESCRIPTION>PRE EARNINGS RELEASE 2Q 2013 NSE
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Nu Skin Enterprises, Inc.
    Document created using Disclosure Solutions PROFILE 1.2.0.0
    Copyright 1995 - 2013 Thomson Reuters Accelus.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: Arial; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D.C. 20549</div>

<div style="LINE-HEIGHT: 12.55pt"><br style="LINE-HEIGHT: 12.55pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 18.25pt; FONT-FAMILY: Arial; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</div>

<div style="LINE-HEIGHT: 12.55pt"><br style="LINE-HEIGHT: 12.55pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.1%; VERTICAL-ALIGN: bottom" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">July 9, 2013</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.1%; VERTICAL-ALIGN: bottom" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 18.25pt; FONT-FAMILY: Arial; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NU SKIN ENTERPRISES, INC.</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 23.36%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 26.55%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">001-12421</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: bottom">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 23.54%; VERTICAL-ALIGN: bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">87-0565309</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation)</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 11.4pt">&#160;</div>
</td>
<td style="WIDTH: 26.55%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Commission File Number)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 11.4pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(IRS Employer Identification Number)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.1%; VERTICAL-ALIGN: middle" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">75 West Center Street</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Provo, UT 84601</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Address of principal executive offices and zip code)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.1%; VERTICAL-ALIGN: bottom" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(801) 345-1000</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Registrant's telephone number, including area code)</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.1%; VERTICAL-ALIGN: bottom" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">N/A</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">(Former name or former address, if changed since last report)</div>

<div style="LINE-HEIGHT: 11.4pt">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 13.7pt">&#160;</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 12.55pt"><br style="LINE-HEIGHT: 12.55pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt"><font style="FONT-FAMILY: Arial; FONT-SIZE: 12pt">&#9633;</font><font style="FONT-SIZE: 6pt" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt"><font style="FONT-FAMILY: Arial; FONT-SIZE: 12pt">&#9633;</font><font style="FONT-SIZE: 6pt" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt">
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: Arial; FONT-SIZE: 12pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="WIDTH: auto; FONT-FAMILY: Arial; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt">
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt; FONT-FAMILY: Arial; FONT-SIZE: 12pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="WIDTH: auto; FONT-FAMILY: Arial; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt">&#160;</div>

<div style="LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt">&#160;</div>

<div style="LINE-HEIGHT: 12pt; MARGIN-BOTTOM: 12pt"><br style="LINE-HEIGHT: 12pt">
 &#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<hr style="PAGE-BREAK-AFTER: always; MARGIN: 4px 0px; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000; CLEAR: both" id="DSPFPageBreak" noshade="noshade">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; COLOR: #000000; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; COLOR: #000000; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.02 Results of Operations and Financial Condition.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">On July 9, 2013, Nu Skin Enterprises, Inc. (the "Company") issued a press release announcing its preliminary financial results for the second quarter</font> ended June 30, 2013<font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">, and certain other information. A copy of the Company's press release is attached as Exhibit 99.1 to this report and incorporated by reference.</font></div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">The information furnished pursuant to this Item 2.02 and the exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements and Exhibits</font></div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">(d) Exhibit.</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 13.5%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">99.1</div>
</td>
<td style="WIDTH: 86.5%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Nu Skin Enterprises' press release dated July 9, 2013, regarding preliminary financial results for the second quarter</font> ended June 30, 2013<font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">.</font></div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; TEXT-INDENT: -108pt; MARGIN-BOTTOM: 12pt; MARGIN-LEFT: 108pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<hr style="PAGE-BREAK-AFTER: always; MARGIN: 4px 0px; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000; CLEAR: both" id="DSPFPageBreak" noshade="noshade">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-LEFT: 216pt; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NU SKIN ENTERPRISES, INC.</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"><br>
</font> (Registrant)</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-LEFT: 216pt; FONT-SIZE: 10pt"><u>/s/ Ritch N. Wood</u></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-LEFT: 216pt; FONT-SIZE: 10pt">Ritch N. Wood<font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"><br>
</font> Chief Financial Officer</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="LINE-HEIGHT: 13.7pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt">Date: &#160;July 9, 2013</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt">&#160;</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt">&#160;</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt"><br style="LINE-HEIGHT: 13.7pt">
 &#160;</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<hr style="PAGE-BREAK-AFTER: always; MARGIN: 4px 0px; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000; CLEAR: both" id="DSPFPageBreak" noshade="noshade">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.7pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt"><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><u>Exhibit No.</u></font><font style="FONT-SIZE: 5.02pt" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><u>Exhibit Description</u></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt">
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 162pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">99.1</td>
<td style="WIDTH: auto; FONT-FAMILY: Arial; FONT-SIZE: 10pt; VERTICAL-ALIGN: top"><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Nu Skin Enterprises' press release dated July 9, 2013, regarding preliminary financial results for the second quarter</font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> ended June 30, 2013</font><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">.</font></td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 13.7pt; TEXT-INDENT: -216pt; MARGIN-BOTTOM: 12pt; MARGIN-LEFT: 216pt"><br style="LINE-HEIGHT: 13.7pt">
</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt">&#160;</div>

<div style="LINE-HEIGHT: 13.7pt; MARGIN-BOTTOM: 12pt"><br style="LINE-HEIGHT: 13.7pt">
 &#160;</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE DATED JULY 9, 2013 REGARDING Q2 2013 NUS EARNINGS
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Nu Skin Enterprises, Inc.
    Document created using Disclosure Solutions PROFILE 1.2.0.0
    Copyright 1995 - 2013 Thomson Reuters Accelus.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: Arial; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 27.35pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 27.35pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 27.35pt"><img src="image0.jpg"></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 26.2pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 26.2pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FOR IMMEDIATE RELEASE</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; MARGIN-LEFT: 4.5pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONTACTS:</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; MARGIN-LEFT: 4.5pt; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Investors &#8212; Scott Pond (801) 345-2657, </font><font style="FONT-FAMILY: Arial; COLOR: #0063ff; FONT-SIZE: 10pt"><u>spond@nuskin.com</u></font></font><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"><br>
</font><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Media &#8212; Kara Schneck (801) 345-2116, </font><font style="FONT-FAMILY: Arial; COLOR: #0063ff; FONT-SIZE: 10pt"><u>kschneck@nuskin.com</u></font></font></div>

<div style="LINE-HEIGHT: 15.75pt"><br style="LINE-HEIGHT: 15.75pt">
</div>

<div style="LINE-HEIGHT: 13.1pt; MARGIN-BOTTOM: 10pt"><br style="LINE-HEIGHT: 13.1pt">
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.1pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NU SKIN ENTERPRISES UPDATES SECOND-QUARTER RESULTS</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.1pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RAISES 2013 GUIDANCE</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 13.1pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Company announces date for full second-quarter earnings</div>

<div style="LINE-HEIGHT: 19.65pt"><br style="LINE-HEIGHT: 19.65pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">PROVO, Utah &#8212; July 9, 2013 &#8212; Nu Skin Enterprises, Inc. (NYSE: NUS) today announced a significant increase to estimated revenue and earnings per share for the second quarter of 2013. Revenue is now estimated to be about $680 million, with estimated earnings per share of approximately $1.20. Foreign currency fluctuations negatively impacted second-quarter revenue by approximately 3 percent. &#160;Prior revenue guidance was $570 to $580 million, with earnings per share guidance of $0.91 to $0.95.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: normal; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Additionally, the company announced that it is increasing its full-year 2013 revenue guidance by $320 million to $2.83 to $2.86 billion, including a negative 5 percent impact from foreign currency fluctuations. The company now expects 2013 earnings to be $4.85 to $5.00 per share.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: normal; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: normal">"Our second-quarter results reflect the strong momentum of our business," stated Truman Hunt, president and chief executive officer. "After a record 2012 that included impressive ageLOC product launches in the second quarter, we continue to generate healthy gains throughout our global business, particularly in the Greater China, North Asia and Americas regions.</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">-more-</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<hr style="PAGE-BREAK-AFTER: always; MARGIN: 4px 0px; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000; CLEAR: both" id="DSPFPageBreak" noshade="noshade">
</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Nu Skin Enterprises, Inc.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">July 9, 2013<font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"><br>
</font>Page<font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt">&#160;2</font></div>
</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt"><br style="LINE-HEIGHT: 19.65pt">
 &#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">"We look forward to sharing full second-quarter results with our shareholders on Aug. 1 during our quarterly conference call. In addition, we will provide updates on our expectations for the remainder of the year, which include the limited-time introduction of our new ageLOC TR90 weight management system in September and October. We continue to expect this product introduction to be the largest in our history and anticipate a net impact of approximately $380 to $400 million from TR90 sales in the second half of the year," concluded Hunt.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">Nu Skin will release its full second-quarter 2013 results prior to the market opening on Thursday, Aug. 1. The Nu Skin management team will host a conference call with the investment community later that same day beginning at 11 a.m. (EDT). The webcast of the conference call, including the financial information to be presented, will be available on the investor section of the company's web site at <font style="FONT-FAMILY: Arial; COLOR: #0000ff; FONT-SIZE: 10pt"><u>www.nuskin.com</u></font>. A replay of the webcast will be available at the same location through Aug. 15, 2013.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Nu Skin Enterprises, Inc.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> suite of products including the ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> R<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> nutritional supplement, ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Galvanic Spa System and ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Galvanic Body Spa&#8482;, as well as the ageLOC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 19.65pt; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">-more-</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both">
<hr style="PAGE-BREAK-AFTER: always; MARGIN: 4px 0px; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000; CLEAR: both" noshade="noshade">
</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">&#160;</div>

<div style="LINE-HEIGHT: 19.65pt; MARGIN-BOTTOM: 10pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">Nu Skin Enterprises, Inc.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 15.75pt; FONT-FAMILY: Arial; COLOR: #000000; FONT-SIZE: 10pt">July 9, 2013<font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"><br>
</font>Page<font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"> 3</font></div>
</div>
</div>

<div style="LINE-HEIGHT: 13.1pt; MARGIN-BOTTOM: 10pt"><br style="LINE-HEIGHT: 13.1pt">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; MARGIN-BOTTOM: 10pt; FONT-SIZE: 10pt">
<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;"><font style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Please Note:</font> <font style="FONT-WEIGHT: normal">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, strategies and new product introductions; statements of estimates or projections regarding revenue, earnings per share, foreign currency impact and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.</font></div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">estimates and guidance concerning anticipated revenue, earnings per share and the impact of foreign currency are preliminary estimates, and actual results may differ from the estimates and guidance provided based on a number of factors, including higher than anticipated expenses, changes in reserves and other financial statement or audit adjustments;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">challenging economic conditions globally;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">risks associated with general inquiries and complaints to consumer protection agencies in Japan regarding the activities of some distributors;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">continued regulatory scrutiny and investigations in Mainland China, which have from time to time in the past, and could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others;</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and</div>
</td>
</tr>
</table>
</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: Arial; FONT-SIZE: 10pt" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Symbol, serif; MARGIN-LEFT: 18pt; FONT-SIZE: 10pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 11.4pt; FONT-STYLE: italic; FONT-FAMILY: Arial; FONT-SIZE: 10pt">continued competitive pressures in the company's markets.</div>
</td>
</tr>
</table>
</div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. &#160;The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.</div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div>

<div style="text-align: center; line-height: 11.4pt; font-style: italic; text-indent: -9pt; margin-bottom: 10pt; margin-left: 9pt; font-family: Arial; font-size: 10pt; font-weight: bold;">###</div>

<div style="text-align: left; line-height: 11.4pt; font-style: italic; margin-bottom: 10pt; font-family: Arial; font-size: 10pt; font-weight: bold;">&#160;</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`#``10#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^D)"J68@
M*!DD]J"0JDD@`#))[5XYXW\;2ZS/)I^GR%-.0[693@SGU_W?0=^M;4*$JLK(
MY<7BX8:'-+?HCJ=>^)FGZ>[6^F1_;IEX,F<1`_7JWX?G5.R'C_Q$@G-U'I=J
M_*YC"DCV&"WYD51^'&A:7(PU*^N;66ZW8M[8R*2F/XBOKZ?G7JM;U94Z+Y(*
M[[LX\/"MBH^UJRLGLEI]YQ!\(>)=F1XQNO,]"AQ_Z%6;?7'C[PRIGEFBU.S3
MEF$8;`]\`,/UKTFBLEB)?:2?R.F6!A;]W)Q?J_U.*\/_`!(TW572WOE^PW+<
M`LV8V/LW;\:[6O(/B)H6EVES]OTVYME=VQ<6B2+D$_Q!?YBI/`GC>2QGBTG5
M)2UHY"PS.>8CV!/]W^7TK:IAHSA[2E]QR4<?.E5]AB?D_P#,];HHHKA/8"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@#C/B#JEREA!HFG(\E]J)*[8_O>6.OY]/IFL+2_A0[PJ^J7YC<CF*W4
M''U8_P"%=7JEWI_AZ[O-?U-B97"V]L@&6V`9(4>[$DGT`KEO^%@>)-49FT;0
MMT(/#>6\I_,8%=])U>2U+1=6>-B5AW6<L1J^B7;Y=Q]]\)D$9;3M3<2#D+.@
MP?Q'3\JAT#Q/JWAC5UT/Q)O,#$*DLAR8\\`AOXD_E^E.C^)&M:;.L>N:+L4G
MJJ-$WX;L@UL>)8M.\:^#)-0T]A)+;*9(SC#*0,LA'N.WTJFZFD:ZO%]3-1H:
MU,(^6:Z:ZKT9VS,JH79@%`R23P!7E6K>(-:\:ZK)I7A_?'8IPSJ=N\?WG;LO
MH.]7[[7YG^$,-QO)GF46C-WX)4_FJG\ZU],.F^`?"$$EZ=LTH#R!1EY9",[1
M].GI65.'LKNUY7LO\SHKU?K#45+EA;F;]=D8UG\)8!&#?:G(TAZB!``/Q.<U
M4U;X4SQ0M)I5[Y[`9\F8!2?HPXS]<5*WQ%U_5)6&BZ(&0'KL>4_CC`%.7XB:
M_I<JC7-"*1$_>"-$?PW9!K=/%)WOKVT.1K+7&W*[=]3HO`>KSW^C/8WP=;_3
MW\F57&&Q_"3[]OPKJZY[2YK'5[^#Q!I;Y6>,V]RN,'CE=P_O`\?1JZ&N&M;G
M;M8]C#7]FDW>W7NN@4445D=`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110!P5YI/_"5_$&X2]RVFZ5&B^7GAW8;L?X_
M05MW?C'PUH[_`&-[Z)#'\OEP(6">WRC`^E8OC6YF\/:1J<ULQCFU2Z15=3RJ
M^6`W_H)'XUY#7ITJ"KQ3D]%M^I\_B<:\)-Q@KR;;;?KHON/H2"\T7Q5I\L<4
MD%[;MQ(AZCZ@\@^]<;X6T^3P]XYU30MS/9SVYECW=QD8/UP2/PK@/#^KS:'K
M=M>PN0JN%E4'AT)Y!KUB;!^*4##OI3<_\#J9TG1O!.Z:_(THXF.*Y*C5I1:7
MR9R44:M\.-)B(RAU@*1[;FK4US3'\4_$Q--G9OL5E`KR`'L<$CZDD#Z"LV'_
M`))]I'_8:'_H;5U-C*D'Q$\13O\`=CLX6)]@N33E)Q;DM]?S1-.$9QC&6SY;
M_)-FW>:KHOAFTBBN)X+.(#$<2CDCV4<U4M?%/AOQ`38I=PS&4;?)G0KO]@&'
M->):KJ=QK&ISW]RY:25L@$_='91[`53!((()!'(([5<<`N6[>IC/.I<]HQ7*
M>O:)IK>%/'LFFV[,=.U*!I85)SM9>WX#/X$5WE<7X2GF\16.C:I<-NFL/.AD
M<]6)``/Y8KM*X<0WS:[]3V<$DJ=X?"W=>C2?YW"BBBL#K"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`.2^(FE2:GX5
MD>%2TMHXG`'4J`0WZ'/X5XE7TS@$8(R#7D'CCP/)I<TFIZ9$7L'.Z2-1S`?_
M`(G^5>E@:Z7[N7R/!S?!RD_;P^?^9PIZ5[,O/Q(LC_U!S_Z%7C!Z5[.O_)2+
M+_L#_P#LU;XOIZ,X\LZ^L?U.9A_Y)]I'_8:'_H;5T#_\C?XN_P"P:G_H%<_#
M_P`D^TC_`+#0_P#0VKH'_P"1O\7?]@U/_0*YY[OY_FCMI?#'_MW_`-)D>/#H
M*6D'W17HO@3P-)<31:OJL)2!"'@@<<R'LS#T]!W^G7T*M6-./-(\3#X>>(J<
MD#L_`^E2:1X4M89E*S2YFD4]BW0?EBNCHHKP)R<Y.3ZGVM*FJ<%!;(****DL
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`*"`1@C(-%%`'$Z_\-M-U1GGL&^PW#<D*N8V/^[V_#\JT/[(O5\;6VH>6
M#:1Z<;=I`P^_G.,=:Z:BMO;S:LW<YOJE)2YHJSNGIY'FL6B:H/!.F6AL)A<1
MZJ)7CQRJ;F.X^U="NB7LGB?Q!<LBI;WMHD$,A8'+;<'CK@5U-%.5>3O_`%YD
MPP<(VUVM^":_4X[P]\.]+T=DN+H_;KI>0TBX13[+_4YKL:**SG4E-WD[FU*C
M3HQY::L@HHHJ#4****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`(;MF2RG=#AEC8@^AQ65X:UO\`M>P59QLO(T!D
M4C&X'HX]C6G??\@^Y_ZY-_(US=EI\TOAO2M0L,#4+:`;`>DJ]T/L>WO0!UE8
M6C7]U=>'[JYFEW3(\P5L`8VDXK2TW4(=3LDN8<C/#HW5&'53[BL3P_\`\BK>
M?]=+C^9H`UM"N9;O0K*XG??+)$&=L8R:T*RO#/\`R+6G?]<5K5H`RO#EW/?:
M+'/<R;Y2[@M@#HQ`Z5)K.HOIMB'AC$EQ+(L4*'H7;IGVJIX2_P"1>A_ZZ2?^
MAFK6MZ=)J5BJP2".YAD6:%CT#+TS[4`5!I&KNOF2:]*L_7$<*^6#Z8[BK%[+
M?67AJYEFGC:\BA9O,C7`R.AP:KVWB-(Y5M=7@>PNCP"_^K<_[+=/SJUX@Y\.
MZACO`W\J`+-K<@:5!<W$@`\E7D=N!TR36=87=[K%X+N-FM]+3B-2HW7!_O'/
M1?3UK-TP'Q(D4,S;-/LU1&M\X>9P!RX[+Z#O76`!5"J``!@`=J`,F.\N#XLF
MLC)_HZV:R!,#AMV,YZU5&NM;>*+G3[H_Z,Q012$<(Y7[I/OSCWI\7_(]7'_7
M@O\`Z'4,=G#J&O:]:W"[HI(X0?4?*<$>XH`Z2LI[N<>*X[,2?Z.;,R%,#[V[
M&<]>E1:/>SPSOI&H-F[A7,4I_P"6\?9OJ.]-D_Y'B'_KP/\`Z'0!N4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`5[[_D'W/\`UR;^
M1JCX9_Y%G3O^N(K3FC$T$D1)`=2I(]Q4.GV::=I\%G&S.D*!`S=30!DZA$^B
MZ@VKVRDVLI`O8E_]&`>H[^U1>&%^T>&;A(R#YDLP4_4G%=&0&4JP!!&"#WJI
MING0Z7;-;V^1$9&=5/\`#DYQ]*`*/A2=9?#MK&#B2`&&1>ZLIQ@UJ7=S'9VD
MMS,P6.-2S$UG76@12W;WEI=3V-S)_K&@(P_^\IX)J-?#@FD1M2U"YOE0[EBD
M(5,^ZCK0`_PM"\/AVU\Q2K.&DP>P8DC]#6OD9QGD]*4<#`JAJ6DV^J",R/+%
M+$28Y8G*LA-`%FZM8+RV>"YB62)A\RL.*Y:T=W\!:@K.SQQB:.%SW09`K2;P
M_=3+Y-UK=Y-;GAHP%0L/0L!FM&;38)-)?38QY,#1&(!/X1[4`9+:9,UC8ZEI
MI$>H1VZ`@\+.NT?(W]#VK4TO5(=4MRZ!HY8SMFA?[T;>AJU;PBWMHH%)*QH$
M!/4X&*IS:3$^J1ZC#*\%PHVR%,8E7T8=_K0!1B_Y'JX_Z\%_]#IVG?\`(UZS
M_N0_^@FKZZ=&NL/J0=_,>$0E.,8!SGZTL&GQP:E=WJNQ>Y"!E.,#:,<4`0ZQ
MIAU"W1X7\J\@.^WE_NMZ'V/0UC:9J!U'Q9$\D1BN(K)HIXC_``.'Y_#N*ZNJ
M?]FP?VL-24;9_*,38Z,,C&?<8H`;)J<4<QCV.0,Y88[=<#J<>WH:N@@@$'(/
M(-9LNEL]QO210,MM8@[D#9W`=CU/7I6DBA$5%&%48`H`6BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`(YHA-"T;,ZAAU1BI'T(Y%<]'YEKI
MEQ=+/>2R)>^4%,S.2HG"X`)QG'%=+57^S[?R&APVQIO//S?Q;]_\Z`,+5=3N
M7FD5(KVV46I.TX5F/F(/EP>N"1^-7F9H-"U&:(7L,BPNRFYD+,"%.",DU=O-
M,M[YBTN\,8S'N1L$#<&X]\J*$TY!:3VTL\\\<RE6\U\D`C!`IIZDR3<6D8X^
MT:6FE7,=[<S+=21PS0SR;]V\?>4GD$'GTQFLNSNI[N2V%S+J\N;&!\V;D`,Q
M?);!')P/RKIK31+6UFBE,EQ/)"-L1GE+^6,8^4=`<<9ZU+8Z7:Z><VZL/W20
M\MGY5SC_`-"-;>TBD^YR>PFVNB.:AGF;^TI3+J_G0R76R3>?LXVE@O?M@=NM
M)YLT/AR2Y$FLQR,MN&>>4MD,ZAMF"3G!/YUU*:=;I:7%J%;RIVD9QNZER2W\
MS52+0;>.W^SM<7<L/R8268L%V,&&/Q`I^UB+ZO.WR?WG-M>7,BQK#<:G)8OJ
M'E1;6VW#`1/O7G!P'`Z\\'VJ\]Y?V%_9_9ENY;=+:2:XMKEM\S+O49!R?F&<
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MWLA;H5,\\H*[3YLF[N3GZ\_H*KV^C6]NT):2>98,>4DTFY4P,`@=,CU.:P>Y
MUQ344C(MI93IMU<$ZB)TBG83/(3%D;L8&['TX[4ZZU>\_LD6RNJ:E%C[2X'"
MJI&6'^\",?4^AK331($CDA^T71@D5U,)E^7#9SC\ZM3V-O<0RQ/&`)4".R\,
M5'09]LG\Z11GVUO)J@GN9;RYC/G21QI#(4$81BO3N3C/.>M4;75;X3+=2R"6
MWB@`N$1?2213*O\`WSDCT/M6O-I$$LTDB2W$'FG,JPRE%<],GT..XP:L065O
M;/NAC"8B6(*.@5<X&/Q-`&%)--(@NII;I]/5YPSVLA!3$AVL<<LH7TS]#5F6
MU236[94N[LPS022D+<N%)!3!&#TPQZ>M63H5HL(@A>X@@^;,,4I5&#$DC'U)
MZ8JX+2$7$4RKAHHS$@!X"G'&/^`B@#G[*YEDU*%(9[MK@W$QF64MY1B5V'&>
M,CY0-OXU)9:JM]JDD37FZWO0ZP(CX:/9QG(Y&X9;\*U9=)M98$B(==CNZNKD
M,I;.[!]#N-2O8V[P00[-J0,C1!3C:5Z8_E]*`.?9)(-,U2=;J]9XK@Q)_I#$
MA<KP,GKR>:M[-QM(E.HP)+<E7$T[;B!&QX.XD#('?M6E)IEO):W%O\ZI<.9'
M*M@[N.0>W05$VD*T:JUY>,R/O20R_,IP1QQTP30!2GM99FOM&,IG1[82PM,<
MF-B2,$]2,C(/7K4G]DWBWP>&[\NT6=)!;@G&%4#'L.IQZX-7K?38;:02(\QD
M)R[M(29.,#=Z@=AT%7*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
+"BBB@`HHHH`__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
